Form 4: Zoetis EVP Rimma Driscoll Receives Equity Awards

Zoetis Inc. Executive Vice President Rimma Driscoll was granted new restricted stock units and stock options as part of the company's equity incentive plan.

Summary

• Rimma Driscoll, Executive Vice President of Zoetis Inc., was granted 2,323 Restricted Stock Units (RSUs) and 9,191 stock options on February 18, 2026.
• These new RSUs and options will vest in one-third increments on the first, second, and third anniversaries of the grant date, subject to continued service.
• The stock options granted on February 18, 2026, have an exercise price of $129.13.
• The filing also details previously granted RSUs and stock options with various vesting schedules and exercise prices, including 1,362.6338 RSUs and 5,235 options granted on February 19, 2025; 222 RSUs and 2,500 options granted on February 6, 2024; 2,077 options granted on February 8, 2023; and 5,271 options granted between February 12, 2019, and February 8, 2022.
• All equity awards are granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine executive compensation disclosure that is part of the company's established incentive plan.

Positives

• The grant of new equity awards aligns the executive's interests with long-term shareholder value through performance-based compensation.
• The continued use of the 2013 Equity and Incentive Plan indicates a stable and established compensation framework.

Future Outlook

The vesting schedules for the granted RSUs and stock options extend into 2027 and beyond, indicating a long-term incentive structure for the executive.

Industry Context

StockSavvy.ai notes that equity-based compensation, such as restricted stock units and stock options, is a standard practice across industries, particularly in the pharmaceutical and animal health sectors, to attract, retain, and incentivize key executives by aligning their financial interests with long-term company performance.

Comparison to Industry Standards

• Equity incentive plans like Zoetis Inc.'s Amended and Restated 2013 Equity and Incentive Plan are common across large-cap pharmaceutical and animal health companies such as Merck & Co. (MRK), Elanco Animal Health (ELAN), and IDEXX Laboratories (IDXX).
• The vesting schedule of one-third annually over three years for RSUs and stock options is a typical structure designed to promote executive retention and long-term performance.
• The mix of RSUs (full value shares) and stock options (leveraged upside potential) is a balanced approach to executive compensation, frequently observed in peer companies.

Related Party Transactions

• The grant of restricted stock units and stock options to Executive Vice President Rimma Driscoll constitutes a related party transaction, as it involves an executive officer and the company.

Stakeholder Impact

• Shareholders: The equity grants align executive incentives with shareholder interests, potentially leading to long-term value creation. However, they also represent potential dilution upon vesting and exercise.
• Employees: No direct impact on general employees is mentioned, but executive compensation practices can influence overall company culture and morale.

Next Steps

• Vesting of 2,323 Restricted Stock Units and 9,191 stock options on the first, second, and third anniversaries of February 18, 2026.
• Vesting of 1,362.6338 Restricted Stock Units and 5,235 stock options on the first, second, and third anniversaries of February 19, 2025.
• Vesting of 222 Restricted Stock Units and 2,500 stock options on the first, second, and third anniversaries of February 6, 2024.
• Expiration of stock options on the tenth anniversary of their respective grant dates.

Key Dates

Recommendation

This Form 4 filing details routine equity compensation grants to an executive and does not contain information that would typically warrant a change in investment recommendation. It reflects standard corporate governance and incentive practices.

Keywords

Zoetis, ZTS, Form 4, SEC filing, insider transaction, equity award, restricted stock units, stock options, executive compensation, Rimma Driscoll, incentive plan